PIERSANTI, GIOVANNI
 Distribuzione geografica
Continente #
NA - Nord America 13.114
EU - Europa 7.238
AS - Asia 3.826
SA - Sud America 374
Continente sconosciuto - Info sul continente non disponibili 325
AF - Africa 55
OC - Oceania 25
Totale 24.957
Nazione #
US - Stati Uniti d'America 12.887
IT - Italia 2.219
GB - Regno Unito 1.914
CN - Cina 1.741
SG - Singapore 1.092
UA - Ucraina 760
RU - Federazione Russa 565
SE - Svezia 429
DE - Germania 348
FI - Finlandia 337
BR - Brasile 290
TR - Turchia 283
FR - Francia 216
VN - Vietnam 195
IE - Irlanda 158
IN - India 128
CA - Canada 116
BD - Bangladesh 70
NL - Olanda 64
KR - Corea 63
JP - Giappone 56
HK - Hong Kong 52
PL - Polonia 52
MX - Messico 39
AR - Argentina 29
BE - Belgio 27
AU - Australia 22
ES - Italia 21
ZA - Sudafrica 18
CH - Svizzera 17
EC - Ecuador 16
ID - Indonesia 15
IQ - Iraq 15
LT - Lituania 14
AE - Emirati Arabi Uniti 13
AT - Austria 11
CL - Cile 11
CR - Costa Rica 11
IR - Iran 10
PK - Pakistan 10
VE - Venezuela 10
RO - Romania 9
SA - Arabia Saudita 9
UZ - Uzbekistan 9
BG - Bulgaria 8
GR - Grecia 8
PE - Perù 8
GT - Guatemala 7
JM - Giamaica 7
KE - Kenya 7
MA - Marocco 7
PH - Filippine 7
PR - Porto Rico 7
SV - El Salvador 7
EG - Egitto 6
HN - Honduras 6
HR - Croazia 6
HU - Ungheria 6
IL - Israele 6
KZ - Kazakistan 6
NI - Nicaragua 6
PA - Panama 6
PT - Portogallo 6
TT - Trinidad e Tobago 6
AM - Armenia 5
CZ - Repubblica Ceca 5
DK - Danimarca 5
TH - Thailandia 5
AZ - Azerbaigian 4
BH - Bahrain 4
EE - Estonia 4
JO - Giordania 4
KG - Kirghizistan 4
LV - Lettonia 4
TN - Tunisia 4
BY - Bielorussia 3
CO - Colombia 3
CY - Cipro 3
EU - Europa 3
MD - Moldavia 3
MY - Malesia 3
NO - Norvegia 3
OM - Oman 3
PY - Paraguay 3
RS - Serbia 3
TW - Taiwan 3
AL - Albania 2
AO - Angola 2
BO - Bolivia 2
CI - Costa d'Avorio 2
CW - ???statistics.table.value.countryCode.CW??? 2
DO - Repubblica Dominicana 2
IS - Islanda 2
LU - Lussemburgo 2
MQ - Martinica 2
SK - Slovacchia (Repubblica Slovacca) 2
SM - San Marino 2
SN - Senegal 2
UY - Uruguay 2
BA - Bosnia-Erzegovina 1
Totale 24.612
Città #
Southend 1.629
Fairfield 1.461
Woodbridge 1.393
Ashburn 1.284
Houston 904
Ann Arbor 827
Seattle 608
Jacksonville 593
Chandler 580
Urbino 566
Cambridge 564
Singapore 557
San Jose 497
Wilmington 476
Nanjing 293
Beijing 289
Dallas 281
Boardman 219
Council Bluffs 210
Izmir 190
New York 181
Dublin 155
Helsinki 150
Los Angeles 148
Santa Clara 118
Lauterbourg 106
Milan 97
Nanchang 92
Princeton 92
Rome 87
San Mateo 81
Munich 77
Tianjin 75
Shenyang 72
Ho Chi Minh City 71
Hebei 65
Moscow 64
Changsha 63
San Diego 60
London 58
Seongnam 57
Istanbul 52
Jiaxing 52
Chicago 50
Buffalo 48
Hong Kong 45
Düsseldorf 43
São Paulo 43
Bremen 40
Hanoi 40
San Francisco 40
Warsaw 38
Kunming 37
Orem 37
Toronto 36
Montreal 34
Shanghai 34
The Dalles 34
Chennai 32
Velikiy Novgorod 31
Bologna 30
Turku 30
Jinan 29
Brooklyn 28
Denver 28
Brussels 26
Frankfurt am Main 26
Hangzhou 26
Ancona 25
Stockholm 25
Tokyo 25
Poplar 24
Bellaria-Igea Marina 23
Guangzhou 22
Naples 21
Phoenix 21
Atlanta 20
Augusta 19
Columbus 19
Manchester 19
Mexico City 19
Nuremberg 16
Paris 16
Turin 16
Amsterdam 15
Redondo Beach 15
Zhengzhou 15
Dong Ket 14
Ningbo 14
Elk Grove Village 13
Johannesburg 13
North Bergen 13
Ankara 12
Des Moines 12
Jesi 12
Latina 12
Mumbai 12
Rio de Janeiro 12
Boston 11
Lappeenranta 11
Totale 16.915
Nome #
Targeting SARS-CoV-2 by synthetic dual-acting thiol compounds that inhibit Spike/ACE2 interaction and viral protein production 564
Derivatizzazione one-pot di indoli per la sintesi di triptofani, pirroloindoline, bis-indoli & co 506
Iridium-Catalyzed Direct Synthesis of Tryptamine Derivatives from Indoles: Exploiting N-Protected β-Amino Alcohols as Alkylating Agents 401
Observations concerning the synthesis of tryptamine homologues and branched tryptamine derivatives via the borrowing hydrogen process: synthesis of psilocin, bufotenin, and serotonin 375
Synthesis of Boron- and Silicon-Containing Amino Acids through Copper-Catalysed Conjugate Additions to Dehydroalanine Derivatives 362
Metodo di sintesi di derivati del glutatione [Method for the synthesis of glutathione derivatives] 349
An improved synthesis of cis-4-phenyl-2-propionamidotetralin (4-P-PDOT): a selective MT2 melatonin receptor antagonist. 341
A simple, modular synthesis of C4-substituted tryptophan derivatives 332
Iron-Catalyzed Direct C3-Benzylation of Indoles with Benzyl Alcohols through Borrowing Hydrogen 321
A Novel One-Pot Approach of Hexahydropyrrolo[2,3-b]indole Nucleus by a cascade addition/cyclization strategy: Synthesis of (±)-Esermethole 319
One-Pot Synthesis of Biheterocycles Based on Indole and Azole Scaffolds Using Tryptamines and 1,2-Diaza-1,3-dienes as Building Blocks 319
Palladium(II)-Catalyzed Intramolecular Oxidative C−H/C−H Cross-Coupling Reaction of C3,N-linked Biheterocycles: Rapid Access to Polycyclic Nitrogen Heterocycles 318
Palladium(II)-Catalyzed Cross-Dehydrogenative Coupling (CDC) of N-Phthaloyl Dehydroalanine Esters with Simple Arenes: Stereoselective Synthesis of Z-Dehydrophenylalanine Derivatives 315
Synthesis of Tryptamine Derivatives via a Direct, One-Pot Reductive Alkylation of Indoles 310
Cyclohexylcarbamic Acid 3’-or 4’-Substituted Biphenyl-3-yl Esters as Fatty Acid Amide Hydrolase Inhibitors: Synthesis Quantitative Structure–Activity Relationships, and Molecular Modeling Studies 307
Synthesis and Configuration Determination of All Enantiopure Stereoisomers of the Melatonin Receptor Ligand 4-Phenyl-2-propionamidotetralin using an Expedient Optical Resolution of 4-Phenyl-2-tetralone 307
Divergent synthesis of novel 9-deazaxanthine derivatives via late-stage cross-coupling reactions 298
Direct, Regioselective, and Chemoselective Preparation of Novel Boronated Tryptophans by Friedel–Crafts Alkylation 297
Synthesis of 2-substituted tryptophans via a C3- to C2-alkyl migration 290
Development of a practical and sustainable strategy for the synthesis of ST1535 by an iron-catalyzed Kumada cross-coupling reaction 289
Tricyclic Alkylamides as Melatonin Receptor Ligands with Antagonist or Inverse Agonist Activity 286
2-n-Butyl- 9-methyl-8-(1,2,3)triazol-2-yl-9H-purin-6-ylamine and Analogues as A2A Adenosine Receptor Antagonists. Design, Synthesis, and Pharmacological Characterization 282
Concise and Convergent Enantioselective Total Syntheses of (+)- and (-)-Fumimycin 282
Synthesis of (−)-Epi-Indolactam V by an Intramolecular Buchwald–Hartwig C–N Coupling Cyclization Reaction 281
Potent, Metabolically Stable 2-Alkyl-8-(2H-1,2,3-triazol-2-yl)-9H-adenines as Adenosine A2A Receptor Ligands 281
Synthesis of benzo[1,2-d;3,4-d’]diimidazole and 1H-pyrazolo[4,3-b]pyridine as putative A2A receptor antagonists 278
Direct, One-Pot Reductive Alkylation of Anilines with Functionalized Acetals Mediated by Triethylsilane and TFA. Straightforward Route for Unsymmetrically Substituted Ethylenediamine 276
An efficient synthesis of the cyclic form of scalemic 2,4-di-epi-polyoxamic acid exploiting the hetero Diels-Alder approach. 274
Switchable reactivity of acylated alpha, beta-dehydroamino ester in the Friedel-Crafts alkylation of indoles by changing the Lewis acid. 273
Synthesis of Tetrahydropyridazine Amino Acid Derivatives by a Formal [4+2| Cycloaddition Reaction of 1,​2-​Diaza-​1,​3-​dienes with Dehydroalanine Esters 272
Polycyclic Indolines by Acid-Mediated Intramolecular Dearomative Strategy: Reversing Indole Reactivity in the Pictet‒Spengler-Type Reaction 269
New coumarin-urea based receptor for anions: a selective off-on fluorescence response to fluoride 268
An efficient, economical synthesis of hydroxytyrosol and its protected forms via Baeyer–Villiger oxidation 267
Synthesis and Biological Evaluation of Metabolites of 2-n-Butyl-9-methyl-8-[1,2,3]triazol-2-yl-9H-purin-6-ylamine (ST1535), A Potent Antagonist of the A2AAdenosine Receptor for the Treatment of Parkinson’s Disease 264
5-(2-Ethyl-phenyl)-3-(3-methoxy-phenyl)-1H-[1,2,4]triazole (DL-111-IT ) and related compounds induce morphological apoptotic patterns in cultures of human tumor cell lines 263
C3-Alkylation of indoles and oxindoles by alcohols by means of borrowing hydrogen methodology 263
Enantioselective Total Synthesis of (−)-Acylfulvene and (−)-Irofulven 262
Organocatalyzed coupling of indoles with dehydroalanine esters: synthesis of bis(indolyl)propanoates and indolacrylates 262
A Trans-Stereoselective Synthesis of 3-Halo-4-alkyl(aryl)-NH-azetidin-2-ones. 261
Divergent reactions of oxindoles with amino alcohols via the borrowing hydrogen process: oxindole ring opening vs. C3 alkylation 259
Synthesis of (±)-cis-Clavicipitic Acid by a Rh(I)-Catalyzed Intramolecular Imine Reaction 251
Neutral urea-based receptors for phosphates: synthesis and spectrophotometric studies 251
Facile Synthesis of @-Tide-Strand Peptidomimetics: Improved Assembly in Solution and on Solid Phase 250
Short and straightforward synthesis of 1,7-dimethyl-1,4,7,10-tetraazacyclododecane 248
Synthesis, binding and fluorescence studies of a new neutral H-bonding receptor for anions based on 3,5-bis(trifluoromethyl)phenylurea 247
Brønsted Acid-Catalyzed Bisindolization of α-amido acetals: Synthesis and Anticancer activity of bis(indolyl)ethanamino derivatives 246
Organocatalytic Aza-Friedel-Crafts/Lactonization Domino Reaction of Naphthols and Phenols with 2-Acetamidoacrylate to Naphtho- and Benzofuranones Bearing a Quaternary Center at the C3 Position 245
Direct B-alkyl Suzuki-Miyaura cross-coupling of 2-halopurines. Practical synthesis os ST1535, a potent adenosine A2A receptor antagonist 242
Large-Scale Preparation of N-Butanoyl-l-glutathione (C4-GSH) 241
Organocatalytic synthesis of α-quaternary amino acid derivatives via aza-Friedel–Crafts alkylation of indoles with simple α-amidoacrylates 239
Enantioselective total synthesis of (-)-acylfulvene and (-)-irofulven. 237
New family of polyamine macrocycles containing 2,5-diphenyl[1,3,4]oxadiazole as a signaling unit. Synthesis, acid–base and spectrophotometric properties 237
Conformation by NMR of two tetralin-based receptor ligands 232
Hydroxytyrosol derivates prevent apoptosis and autophagy. 231
Diastereo- and enantioselective hydrogenation of a challenging enamide derived from 4-phenyl-2-tetralone: an appealing shortcut towards enantiopure cis-2-aminotetraline derivatives 230
Single‐Step Synthesis of Dehydroalanine Derivatives via a Brønsted Acid‐Catalyzed Multicomponent Reaction 224
Stereoselective synthesis of chiral 3,4,5-trisubstituted 1,5-dihydropyrrol-2-ones from azadienes. 223
Concise catalytic asymmetric synthesis of (R)-4-amino Uhle's ketone 222
Stereochemical aspects of a two-step Staudinger reaction - asymmetric synthesis of chiral azetidine-2-ones. 221
Direct preparation of unsymmetrical difunctionalized cyclen derivatives by an Ugi multicomponent reaction 220
A Versatile Biomimetic Approach to Diindolylmethane Derivatives as Potential Anticancer Agents 216
Synthesis of (E)-8-(3-Chlorostyryl)caffeine Analogues Leading to 9-Deazaxanthine Derivatives as Dual A2AAntagonists/MAO-B Inhibitors 216
New branched macrocyclic ligand and its side-arm, two urea-based receptors for anions: Synthesis, binding studies and crystal structure 216
Synthesis and Quantitative Structure–Activity Relationship of Fatty Acid Amide Hydrolase Inhibitors: Modulation at the N-Portion of Biphenyl-3-yl Alkylcarbamates 213
Total Synthesis of (-)-Clavicipitic Acid via γ,γ-Dimethylallyltryptophan (DMAT) and Chemoselective C-H Hydroxylation 205
Design, Synthesis and Structure–Activity Relationships of Alkylcarbamic Acid Aryl Esters, a New Class of Fatty Acid Amide Hydrolase Inhibitors 205
2-n-butyl-9-methyl-8-(1,2,3)triazol-2yl-9H-purin-6-yl-amine (ST 1535) and analogs as A2a Adenosine receptor antagonists. Design, synthesis and pharmacological characterization 195
Synthesis and Structure–Activity Relationships of FAAH Inhibitors: Cyclohexylcarbamic Acid Biphenyl Esters with Chemical Modulation at the Proximal Phenyl Ring 194
Observations in the synthesis of the core of the antitumor illudins via an enyne ring closing metathesis cascade 192
Identification of a 2,4-diaminopyrimidine scaffold targeting Trypanosoma brucei pteridine reductase 1 from the LIBRA compound library screening campaign 189
Oxidated derivatives of triazolylpurines useful as ligands of the adenosine A2A receptor and their use as medicaments 188
DERIVATIVES OF TRIAZOLYL-IMIDAZOPYRIDINE AND OF THE TRIAZOLYLPURINES USEFUL AS LIGANDS OF THE ADENOSINE A2a RECEPTOR AND THEIR USE AS MEDICAMENTS. 187
Strategies leading to MT2 selective melatonin receptor antagonists 187
Protective action of hydroxytyrosol derivates vs apoptosis: apreliminary study. 186
The collisional behavior of ESI-generated protonated molecules of some carbamate FAAH inhibitors isosteres and its relationships with biological activity 186
N-alchil-O-arilcarbammati come inibitori delle idrolasi delle ammidi degli acidi grassi (FAAH): aspetti meccanicistici 182
Derivatives of triazoly-imidazopyridine useful as ligands of the adenosine A2a receptor ant their use as medicaments 179
Quantifying the Interactions that Contribute to beta-Hairpin Folding 178
Asymmetric Total Synthesis of All Rugulovasine Stereoisomers and Preliminary Evaluation of Their Biological Properties 175
General synthesis of unnatural 4-, 5-, 6-, and 7-bromo-d-tryptophans by means of a regioselective indole alkylation 172
Novel, Chiral, and Enantiopure C2‐Symmetric Thioureas Promote Asymmetric Protio‐Pictet‐Spengler Reactions by Anion‐Binding Catalysis 172
Dithiol Based on L-Cysteine and Cysteamine as a Disulfide-Reducing Agent 172
A Short Synthesis of (−)‐6,7‐Secoagroclavine via Metal‐Free Reductive Coupling 166
Enantioselective organocatalytic strategies to noncanonical α‐amino acids 165
Design, SAR and Biological Activity of a New Class of FAAH Inhibitors: Cyclohexyl Carbamic Acid Biphenyl-3-yl Esters 162
New Receptor For Anions: Signalling Ureido Side-Arms Preorganized On Polyamine Scaffold 161
A New Bis‐Urea Based Cage Receptor for Anions: Synthesis, Solid State Structures and Binding Studies 160
Asymmetric Alkylation of Cyclic Ketones with Dehydroalanine via H-Bond-Directing Enamine Catalysis: Straightforward Access to Enantiopure Unnatural α-Amino Acids 160
Structure-Activity Relationships of Alkylcarbamic Acid Aryl Esters, as Fatty Acid Amide Hydrolase Inhibitors 151
Asymmetric Synthesis and Biological Evaluation of Both Enantiomers of 5- and 6-Boronotryptophan as Potential Boron Delivery Agents for Boron Neutron Capture Therapy 150
Design, Synthesis and SAR of Alkylcarbamic Acid Aryl Esters, a New Class of Fatty Acids Amide Hydrolase Inhibitors 150
Redox modulation by a synthetic thiol compound reduces LPS-induced pro-inflammatory cytokine expression in macrophages via AP-1/NLRP3 axis and influences the crosstalk with endothelial cells 146
Redox modulation via a synthetic thiol compound reshapes energy metabolism in endothelial cells and ameliorates angiogenic expression in a co-culture study with activated macrophages 145
Receptors for Anions Based On Signalling Bisureas 145
Synthesis and Pharmacological Characterization of Potent and Selective Inhibitors of Fatty Acid Amidohydrolase (FAAH) 140
Small molecule-mediated inhibition of the oxidoreductase ERO1A restrains aggressive breast cancer by impairing VEGF and PD-L1 in the tumor microenvironment 139
Correlation between energetics of collisionally activated decompositions, interaction energy and biological potency of carbamates FAAH inhibitors 136
Synthesis and Fluorescence Properties of 4-Cyano and 4-Formyl Melatonin as Putative Melatoninergic Ligands 132
Mass Spectrometry and Pharmacology Activity: The Case of Carbamic Analogs 131
Esteri bifenil-3-ilici dell'acido cicloesilcarbammico quali inibitori dell'enzima FAAH: sintesi, QSAR e modellistica molecolare 129
Totale 23.953
Categoria #
all - tutte 85.357
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 85.357


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022909 0 0 0 138 20 54 70 77 65 90 64 331
2022/20232.167 179 107 54 231 159 347 11 161 435 144 230 109
2023/2024708 56 45 35 89 34 125 28 44 89 60 17 86
2024/20252.129 87 85 369 143 80 138 346 93 199 170 226 193
2025/20265.258 482 427 586 839 539 331 546 204 350 484 277 193
2026/20271.091 167 109 402 413 0 0 0 0 0 0 0 0
Totale 24.957